Directed evolution of adeno-associated virus to an infectious respiratory virus

被引:131
作者
Excoffon, Katherine J. D. A. [1 ]
Koerber, James T. [2 ,3 ,4 ]
Dickey, David D. [1 ]
Murtha, Matthew [5 ,6 ,7 ]
Keshavjee, Shaf [8 ]
Kaspar, Brian K. [5 ,6 ,7 ]
Zabner, Joseph [1 ]
Schaffer, David V. [2 ,3 ,4 ]
机构
[1] Univ Iowa, Dept Internal Med, Iowa City, IA 52241 USA
[2] Univ Calif Berkeley, Dept Chem Engn, Berkeley, CA 94720 USA
[3] Univ Calif Berkeley, Dept Bioengn, Berkeley, CA 94720 USA
[4] Univ Calif Berkeley, Helen Willis Neurosci Inst, Berkeley, CA 94720 USA
[5] Nationwide Childrens Hosp, Res Inst, Dept Pediat, Columbus, OH 43205 USA
[6] Nationwide Childrens Hosp, Res Inst, Childrens Res Inst, Columbus, OH 43205 USA
[7] Ohio State Univ, Columbus, OH 43205 USA
[8] Univ Toronto, Toronto Gen Hosp, Div Thorac Surg, Dept Surg, Toronto, ON M5G 2C4, Canada
关键词
EPITHELIA IN-VITRO; CYSTIC-FIBROSIS; AIRWAY EPITHELIA; GENE-THERAPY; SIALIC-ACID; APICAL SURFACES; VECTOR; ADENOVIRUS; RECEPTOR; BINDING;
D O I
10.1073/pnas.0813365106
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Respiratory viruses evolve to maintain infectivity levels that permit spread yet prevent host and virus extinction, resulting in surprisingly low infection rates. Respiratory viruses harnessed as gene therapy vectors have illustrated this limitation. We used directed evolution in an organotypic human airway model to generate a highly infectious adeno-associated virus. This virus mediated gene transfer more than 100-fold better than parental strains and corrected the cystic fibrosis epithelial Cl- transport defect. Thus, under appropriate selective pressures, viruses can evolve to be more infectious than observed in nature, a finding that holds significant implications for designing vectors for gene therapy and for understanding emerging pathogens.
引用
收藏
页码:3865 / 3870
页数:6
相关论文
共 54 条
  • [1] Adeno-associated virus type 2 contains an integrin α5β1 binding domain essential for viral cell entry
    Asokan, Aravind
    Hamra, Julie B.
    Govindasamy, Lakshmanan
    Agbandje-McKenna, Mavis
    Samulski, Richard J.
    [J]. JOURNAL OF VIROLOGY, 2006, 80 (18) : 8961 - 8969
  • [2] Local interactions select for lower pathogen infectivity
    Boots, Michael
    Mealor, Michael
    [J]. SCIENCE, 2007, 315 (5816) : 1284 - 1286
  • [3] GENE-THERAPY FOR CYSTIC-FIBROSIS USING E1-DELETED ADENOVIRUS - A PHASE-I TRIAL IN THE NASAL CAVITY - THE UNIVERSITY-OF-NORTH-CAROLINA AT CHAPEL-HILL
    BOUCHER, RC
    KNOWLES, MR
    JOHNSON, LG
    OLSEN, JC
    PICKLES, R
    WILSON, JM
    ENGELHARDT, J
    YANG, YP
    GROSSMAN, M
    [J]. HUMAN GENE THERAPY, 1994, 5 (05) : 615 - 639
  • [4] Interfacial enzymology of parvovirus phospholipases A2
    Canaan, S
    Zádori, Z
    Ghomashchi, F
    Bollinger, J
    Sadilek, M
    Moreau, ME
    Tijssen, P
    Gelb, MH
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (15) : 14502 - 14508
  • [5] Glycan topology determines human adaptation of avian H5N1 virus hemagglutinin
    Chandrasekaran, Aarthi
    Srinivasan, Aravind
    Raman, Rahul
    Viswanathan, Karthik
    Raguram, S.
    Tumpey, Terrence M.
    Sasisekharan, V.
    Sasisekharan, Ram
    [J]. NATURE BIOTECHNOLOGY, 2008, 26 (01) : 107 - 113
  • [6] Identification of PDGFR as a receptor for AAV-5 transduction
    Di Pasquale, G
    Davidson, BL
    Stein, CS
    Martins, IS
    Scudiero, D
    Monks, A
    Chiorini, JA
    [J]. NATURE MEDICINE, 2003, 9 (10) : 1306 - 1312
  • [7] Rates of evolutionary change in viruses: patterns and determinants
    Duffy, Siobain
    Shackelton, Laura A.
    Holmes, Edward C.
    [J]. NATURE REVIEWS GENETICS, 2008, 9 (04) : 267 - 276
  • [8] Viral vector-mediated and cell-based therapies for treatment of cystic fibrosis
    Flotte, Terence R.
    Ng, Philip
    Dylla, Doug E.
    McCray, Paul B., Jr.
    Wang, Guoshun
    Kolls, Jay K.
    Hu, Jim
    [J]. MOLECULAR THERAPY, 2007, 15 (02) : 229 - 241
  • [9] Clades of Adeno-associated viruses are widely disseminated in human tissues
    Gao, GP
    Vandenberghe, LH
    Alvira, MR
    Lu, Y
    Calcedo, R
    Zhou, XY
    Wilson, JA
    [J]. JOURNAL OF VIROLOGY, 2004, 78 (12) : 6381 - 6388
  • [10] Genetic capsid modifications allow efficient re-targeting of adeno-associated virus type 2
    Girod, A
    Ried, M
    Wobus, C
    Lahm, H
    Leike, K
    Kleinschmidt, J
    Deléage, G
    Hallek, M
    [J]. NATURE MEDICINE, 1999, 5 (09) : 1052 - 1056